Cargando…
Correction to: ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer
Autores principales: | Wang, Yan, Dan, Liangying, Li, Qianqian, Li, Lili, Zhong, Lan, Shao, Bianfei, Yu, Fang, He, Sanxiu, Tian, Shaorong, He, Jin, Xiao, Qian, Putti, Thomas C., He, Xiaoqian, Feng, Yixiao, Lin, Yong, Xiang, Tingxiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908647/ https://www.ncbi.nlm.nih.gov/pubmed/35264219 http://dx.doi.org/10.1186/s13148-022-01256-0 |
Ejemplares similares
-
ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer
por: Wang, Yan, et al.
Publicado: (2019) -
Depression and stress levels increase risk of liver cancer through epigenetic downregulation of hypocretin
por: Pu, Chunyun, et al.
Publicado: (2020) -
Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma
por: He, Sanxiu, et al.
Publicado: (2021) -
TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells
por: Fan, Jiangxia, et al.
Publicado: (2018) -
DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis
por: Le, Xin, et al.
Publicado: (2020)